Brief: Sigilon Therapeutics Reports Second Quarter 2021 Financial Results
Aug 10 (Reuters) - Sigilon Therapeutics Inc SGTX.O :
* SIGILON THERAPEUTICS REPORTS SECOND QUARTER 2021 FINANCIAL
RESULTS AND BUSINESS HIGHLIGHTS
* SIGILON THERAPEUTICS, INC. - CASH WAS $162.4 MILLION AS OF
JUNE
30, 2021 COMPARED TO $202.2 MILLION AS OF DECEMBER 31, 2020
* SIGILON THERAPEUTICS, INC. - QTRLY NET LOSS PER SHARE
$0.65
Source text for Eikon: ID:nGNX1h9n9m
Further company coverage: SGTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sigilon Therapeutics
See all newsSigilon Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Sigilon Therapeutics Inc expected to post a loss of $4.71 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Micron, Greenbrier, Immunome
Sigilon jumps on Eli Lilly's buyout deal to expand diabetes treatments
U.S. STOCKS ON THE MOVE-Sigilon, Netflix, RenovoRx